ArticlePostepy dermatologii i alergologii2020

Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis.

Ewa Wielosz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.